health news & policy
The ongoing coronavirus disease (COVID-19) pandemic reveals shortcomings in U.S. pandemic preparedness under the Trump administration. The federal government must accelerate its response and marshal available resources to help state and local governments develop medical surge capacity and support community mitigation strategies.
On this year’s World Cancer Day, February 4, 2020, it is particularly fitting that the Executive Board of the World Health Organization (WHO) is meeting to review a draft global strategy to accelerate the elimination of cervical cancer as a global public health problem.
Innovative TB medical products are needed in low-incidence and high-incidence countries alike to support patient-centered care for TB patients and advance toward global TB elimination. If world leaders are serious about the commitments made to ending the global TB epidemic at the UN High-level Meeting in September 2018, investments in TB R&D must match the rhetoric.
